Drug profile · INN
sitagliptin phosphate hydrate
JANUVIA/GLACTIV
sitagliptin phosphate hydrate (JANUVIA/GLACTIV) is a dipeptidyl peptidase iv inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sitagliptin phosphate hydrate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
sitagliptin phosphate hydrate (JANUVIA/GLACTIV) is a dipeptidyl peptidase iv inhibitor.
Key facts
INN sitagliptin phosphate hydrate
Brand JANUVIA/GLACTIV
Mechanism Dipeptidyl peptidase IV inhibitor
Target Dipeptidyl peptidase 4
Mechanism of action
Dipeptidyl peptidase IV inhibitor
Primary target: Dipeptidyl peptidase 4
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sitagliptin phosphate hydrate?
sitagliptin phosphate hydrate (JANUVIA/GLACTIV) is a dipeptidyl peptidase iv inhibitor.
What is the brand name for sitagliptin phosphate hydrate?
JANUVIA/GLACTIV is a marketed brand name for sitagliptin phosphate hydrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.